Results 211 to 220 of about 91,338 (344)

Recurrent Loss of Heterozygosity in Pancreatic Neuroendocrine Tumors. [PDF]

Am J Surg Pathol, 2022
Parilla M, Chapel D, Hechtman JF, Wanjari P, El Jabbour T, Sharma A, Ritterhouse L, Segal J, Vanderbilt C, Klimstra DS, Setia N, Tang L.   +11 more
europepmc   +1 more source

Pharmacogenomics in clinical practice: Biomarker information in Brazilian drug labels

British Journal of Clinical Pharmacology, EarlyView.
This review examines the PGx annotations in package inserts (bulas in Brazilian Portuguese) approved by ANVISA, the Brazilian Health Regulatory Agency, for 19 gene–drug pairs with strong or moderate recommendations for initial dosing alteration in the CPIC (Clinical Pharmacogenetic Implementation Consortion) guidelines and PGx testing required or ...
Guilherme Suarez‐Kurtz
wiley   +1 more source

Impact of clonal TP53 mutations with loss of heterozygosity on adjuvant chemotherapy and immunotherapy in gastric cancer. [PDF]

Br J Cancer
Gu Y, Sun M, Fang H, Shao F, Lin C, Liu H, Li H, He H, Li R, Wang J, Zhang H, Xu J.   +11 more
europepmc   +1 more source

Follicular Thyroid Adenoma and Follicular Thyroid Carcinoma-A Common or Distinct Background? Loss of Heterozygosity in Comprehensive Microarray Study. [PDF]

Cancers (Basel), 2023
Borowczyk M, Dobosz P, Szczepanek-Parulska E, Budny B, Dębicki S, Filipowicz D, Wrotkowska E, Oszywa M, Verburg FA, Janicka-Jedyńska M, Ziemnicka K, Ruchała M.   +11 more
europepmc   +1 more source

Loss of heterozygosity analysis to diagnose adrenal cortical carcinoma [PDF]

, 1999
Andrea Abati, Maria J. Merino
openalex   +1 more source

Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesis.

Blood, 2012
A. Jerez, Y. Sugimoto, H. Makishima, A. Verma, A. Jankowska, B. Przychodzen, V. Visconte, R. Tiu, C. O'keefe, A. Mohamedali, A. Kulasekararaj, A. Pellagatti, K. McGraw, H. Muramatsu, A. Moliterno, M. Sekeres, M. McDevitt, S. Kojima, A. List, J. Boultwood, G. Mufti, J. Maciejewski   +21 more
semanticscholar   +1 more source

When the Clock Is Ticking: The Role of Mitotic Duration in Cell Fate Determination

BioEssays, EarlyView.
Recently, several studies identified mechanisms by which cells measure mitotic duration and how this influences cell fate, leading to normal cell cycle progression or G1 arrest. In light of drug‐resistant cancer cells that continue proliferating even after mitotic errors, understanding these mechanisms opens the door for new potential therapeutic ...
Cornelia Sala, Elmar Schiebel
wiley   +1 more source

Synchronous thyroid cancer and malignant struma ovarii: concordant mutations and microRNA profile, discordant loss of heterozygosity loci. [PDF]

Diagn Pathol, 2023
Seo GT, Minkowitz J, Kapustin DA, Fan J, Minkowitz G, Minkowitz M, Dowling E, Matloob A, Asti D, Dhar M, Shutty C, Brickman A, Urken ML, Brandwein-Weber M, Finkelstein SD.   +14 more
europepmc   +1 more source

Germline DICER1 mutation and associated loss of heterozygosity in a pineoblastoma

Journal of Medical Genetics, 2012
N. Sabbaghian, N. Hamel, A. Srivastava, S. Albrecht, J. Priest, W. Foulkes   +5 more
semanticscholar   +1 more source

ABCC11 Earwax Trait and Genotype Are Suitable Tools for Introductory Labs to Learn Genetics and Molecular Techniques

Biochemistry and Molecular Biology Education, EarlyView.
ABSTRACT Professional experiments in genetic research usually start in a class at university. However, interest in genetic research techniques from an early age is essential. We have continuously performed a short genetic experimental course for high school students using a simple molecular experiment and computer‐based learning for Mendelian ...
Tohru Ohta, Rie Takai, Akiko Yoshida, Durga Paudel, Sarita Giri, Takao Kitagawa, Toshiya Arakawa, Yasuhiro Kuramitsu, Tomoharu Tokutomi   +8 more
wiley   +1 more source